Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: A single-center experience in São Paulo, Brazil

International Journal of Dermatology

Volumn 54, Issue 10, 2015, Pages e383-e388

  Hayashida, Marina Zoega ^a   Fernandes, Victor Miguel Coutinho ^a   de Melo Fernandes, Diana Rosa ^a   Ogawa, Marília Marufuji ^a   Tomimori, Jane ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BRAZIL; CARCINOMA IN SITU; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; RETROSPECTIVE STUDY; SKIN CARCINOMA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; PREVALENCE; SKIN NEOPLASMS; SKIN PIGMENTATION; TIME FACTOR; WARTS;

ADULT; AGED; BRAZIL; CALCINEURIN INHIBITORS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PREVALENCE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SKIN PIGMENTATION; TIME FACTORS; WARTS;

EID: 84942197140     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12632     Document Type: Article

References (31)

1. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498-504.
2. Falsarella PM, Alves-Filho G, Mazzali M. Skin malignancies in renal transplant recipients: a Brazilian center registry. Transplant Proc 2008; 40: 767-768.
3. Athar M, Walsh SB, Kopelovich L, et al. Pathogenesis of non-melanoma skin cancers in organ transplant recipients. Arch Biochem Biophys 2011; 508: 159-163.
4. Fekecs T, Kádár Z, Battyáni Z, et al. Incidence of non-melanoma skin cancer after human organ transplantation: single-center experience in Hungary. Transplant Proc 2010; 42: 2333-2335.
5. Ramsay HM, Fryer AA, Hawley CM, et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950-956.
6. Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221-1226.
7. Karczewski M, Stronka M, Karczewski J, et al. Skin cancer following kidney transplantation: a single-center experience. Transplant Proc 2011; 43: 3760-3761.
8. Mackenzie CA, Wells JE, Lynn KL, et al. First and subsequent non-melanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol Dial Transplant 2010; 25: 300-306.
9. Wisgerhof HC, Edelbroek JRJ, de Fijter JW, et al. Subsequent squamous and basal cell carcinomas in kidney transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010; 89: 1231-1238.
10. Zavos G, Karidis PN, Tsourouflis G, et al. Non-melanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations. Int J Dermatol 2011; 50: 1496-1500.
11. Mackenzie KA, Miller AP, Hock BD, et al. Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Histopathology 2011; 58: 875-885.
12. Ho WL, Murphy GM. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients. Br J Dermatol 2008; 158: 217-224.
13. Brazilian Association for Organ Transplantation. Brazilian Records of Transplants. São Paulo, SP: Brazilian Association for Organ Transplantation, 2012. http://www.abto.org.br/. [Accessed March 30, 2013.]
14. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância de Câncer. Estimativas 2010: Incidência de Câncer no Brasil. Rio de Janeiro: INCA, 2009. http://www1.inca.gov.br/estimativa/2010/index.asp?link=conteudo_view.asp&ID=5 [Accessed November 4, 2013.]
15. Moosa MR, Gralla J. Skin cancer in renal allograft recipients - experience in different ethnic groups residing in the same geographical region. Clin Transplant 2005; 19: 735-741.
16. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-297.
17. Höpfl R, Bens G, Wieland U, et al. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol 1997; 108: 53-56.
18. Tessmer CS, Magalhães LV, Keitel E, et al. Conversion to sirolimus in renal transplant recipients with skin cancer. Transplantation 2006; 82: 1792-1793.
19. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
20. Ulrich C, Schmook T, Sachse M, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30: 622-627.
21. Végso Gy, Tóth M, Hidvégi M, et al. Malignancies after renal transplantation during 33 years at a single center. Pathol Oncol Res 2007; 13: 63-69.
22. Berardinelli L, Messa PG, Pozzoli E, et al. Malignancies in 2753 kidney recipients transplanted during a 39-year experience. Transplant Proc 2009; 41: 1231-1232.
23. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-18; quiz 18-20.
24. Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin cancer prevention in kidney transplantation. N Engl J Med 2012; 367: 329-339.
25. Campbell SA, Walker R, Su Tai S, et al. Randomized controlled trial of sirolimus for renal transplant recipients at high risk for non-melanoma skin cancer. Am J Transplant 2012; 12: 1146-1156.
26. Mathew T, Kreis H, Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18: 446-449.
27. Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17: 581-589.
28. Schena FP, Pascoe MD, Alberu J, et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 2009; 87: 233-242.
29. Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80: 883-889.
30. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal transplant recipients. N Engl J Med 2005; 352: 1317-1323.
31. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005; 56: 23-46.